Enamine Provides Large Novel Diverse Compound Screening Library To BioFocus
News Feb 01, 2012
Kate Hilyard, Vice President Biological Sciences, BioFocus, commented: "We have been impressed by the quality of Enamine's compound collection during our multi-year collaboration. Their strong support services and ability to provide novel compounds using novel chemistry have also been factors driving our decision to extend the current agreement."
Michael Bossert, Business Development Director, Enamine, said: "We are very pleased that BioFocus has decided to continue working with us, which we see as a testament to our growing reputation among professional screening companies and academic research centers. We look forward to a successful renewed relationship."
Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.